HMN 2025: How to Reevaluate ‘seriousness’ in genetic situations

There are variations of opinion in the best way to assess “seriousness” in genetic situations. “In Japan, the seriousness of genetic problems has historically been assessed utilizing slim medical standards, limiting entry to preimplantation genetic testing for monogenic illnesses to solely a small variety of situations.

“However, instances like retinoblastoma—which was solely acknowledged as ‘critical’ after six years of affected person advocacy—underscore the pressing want to include stakeholder values and lived experiences into these assessments,” mentioned Shizuko Takahashi, a Research Fellow at National University of Singapore.

Drawing on a framework proposed by Erika Kleiderman and colleagues, the crew carried out a two-stage survey throughout a stakeholder dialog occasion in Hiroshima in January 2025, exploring how the contributors’ understanding of “seriousness” advanced in response to affected person testimonies and dialogue.

The crew used the current review by Kleiderman and colleagues as a framework for understanding the multifaceted idea of seriousness in genetic situations. The new study, revealed in a current difficulty of the European Journal of Human Genetics, emphasizes the core dimensions and procedural components of seriousness, providing worthwhile insights into the Japanese context.

Many international locations have expanded entry to preimplantation genetic testing for monogenic problems. However, Japan continues to be restrictive, having accepted solely 17 situations below the strict standards set by the Japanese Society of Obstetrics and Gynecology.

The crew carried out their survey in two phases, assessing the contributors’ perceptions earlier than and after affected person testimonies. First, a scientific geneticist defined the medical standards for preimplantation genetic testing for monogenic problems, remedy choices, and out there help assets. The geneticist addressed core dimensions resembling “medical standards,” “entry/availability of remedy,” and “entry/availability of help and assets.”

After that first presentation, people with hereditary cancer—together with sufferers with retinoblastoma and BRCA2 mutations—shared their lived experiences. This juxtaposition of medical data with private narratives allowed contributors to mirror on how “particular person and familial lived experiences,” an important core dimension, affect their perceptions of seriousness.

Before listening to affected person testimonies, 66% of contributors indicated they might contemplate preimplantation genetic testing for monogenic problems if confronted with hereditary cancer, citing a need to forestall the inheritance of debilitating situations. In addition, 89% believed that sufferers needs to be knowledgeable about preimplantation genetic testing for monogenic problems on the time of prognosis, highlighting the significance of entry to data.

However, the contributors’ views shifted notably after listening to affected person tales.

The proportion of contributors who considered preimplantation genetic testing for monogenic problems primarily as a public well being instrument aimed toward decreasing the burden on society considerably decreased (p = 0.005). In addition, there was an elevated emphasis on particular person reproductive autonomy.

The contributors’ favorable attitudes towards marriage, being pregnant, and household planning with preimplantation genetic testing for monogenic problems rose from 54% pre-testimony to 71% post-testimony. These shifts spotlight how firsthand accounts can recalibrate folks’s concepts about “seriousness.”

“Lived experiences profoundly form how folks perceive the ‘seriousness’ of hereditary cancer—and shift perceptions of preimplantation genetic testing for monogenic problems from a instrument of societal burden discount to one in every of particular person reproductive autonomy,” mentioned Rie Iizuka, an assistant professor (particular recognition) at Hiroshima University. This underscores the pressing want to incorporate affected person voices in shaping moral frameworks and coverage selections round genetic testing.

The crew notes that whereas that is the primary study to look at stakeholder views on preimplantation genetic testing for monogenic problems in Japan, it has a few limitations. First, the pattern measurement was comparatively small, and contributors have been drawn from a preimplantation genetic testing for monogenic problems–associated occasion, introducing potential choice bias. Second, the definition of stakeholders on this study was restricted to people affected by hereditary cancer. This excluded these with different genetic situations.

“Future analysis will search to incorporate a broader and extra numerous participant pool, each inside Japan and internationally. Our intention is to supply empirical help for making use of Kleiderman et al’s argument—that assessments of the seriousness of genetic situations ought to meaningfully incorporate stakeholders’ lived experiences—to the factors guiding the implementation of preimplantation genetic testing for monogenic problems,” mentioned Tsutomu Sawai, a professor in ethics at Hiroshima University.